Shutdown stalemate brings US IPO holdouts off the sidelines
The path to going public during the shutdown requires some creativity, as well as the willingness to venture into uncharted territory.
Bloomberg News
Articles
Job searches for holiday season soar with full-time roles scarce
Overall, seasonal jobseekers face a low-energy holiday season, with only a 2.7% pickup in seasonal job postings from employers.
Amazon delivery firms are bailing amid rising costs, meager profit
Amazon launched its Delivery Service Partner program in 2018, offering aspiring entrepreneurs an opportunity to run their own businesses.
Novo, Lilly shares fall as Trump touts ‘much lower’ Ozempic price
Mehmet Oz, head of the Centers for Medicare and Medicaid Services, said talks over the price of weight-loss drugs are still ongoing.
AI jobs shock is coming and firms aren’t ready, financial CEO says
Klarna Group’s chief executive sees the AI boom spelling the end to what he calls “excess profits” in both the banking and software industries, as incumbents are overtaken by faster-moving challengers.
Air travel disruptions add pressure on Congress for shutdown deal
The U.S. air travel disruptions, which hurt both passengers and airlines, are among the most visible examples of how the shutdown is inconveniencing Americans.
Google Cloud seeks workplace dominance with new AI platform
With the launch of Gemini Enterprise, Google Cloud is directly challenging rivals such as Microsoft’s Copilot and OpenAI’s ChatGPT Enterprise.
Millions of workers left out of ‘low-hire, low-fire’ job market
More than a quarter of the jobless have been out of work more than a half-year—the highest share since the mid-2010s excluding the pandemic-era years.
Stellantis planning $10B in US turnaround investments, sources say
Stellantis’ actions would mirror those of companies unveiling big investment plans to curry favor with President Donald Trump and mitigate the impact of tariffs.
$10,000 tickets, bourbon deals: Colleges hunt revenue to pay athletes
Across the college sports ecosystem, universities are under pressure to find new ways to raise revenue, after a landmark federal settlement over student athletes’ name, image and likeness rights opened the door for them to be paid by schools.
Drugmakers buoyed as Trump deal eases worst fears on pricing
Shares in Indianapolis-based Eli Lilly and Co. were on the rise Wednesday after President Trump suggested the company would be next up to cut a deal over drug pricing.
Car sales expected to surge as buyers raced to nab lapsing EV credit
Most industry observers forecast a slowdown in EV sales in the coming quarters, because without the federal incentives, the vehicles are still more expensive than gas-powered cars.
US job openings hold steady, with few layoffs and weak hiring
Another report showed consumer confidence fell in September to a five-month low on concerns about a cooling labor market and the broader economy.
Report predicts $350B nuclear boom in US to power AI
While demand is on the rise for carbon-free fission power as the U.S. races to meet a surge in electricity needs, costs remain high and construction is expected to be slow.
US cuts tariffs on EU-made cars to 15%, cementing trade terms
The U.S. lowered tariffs on auto imports from the European Union to 15% retroactive to Aug. 1, cementing terms of the framework trade agreement the two sides struck almost two months ago.
Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial
Eli Lilly and Co. and Novo Nordisk have been locked in a fierce battle to control the obesity market, which is projected to reach $100 billion by the end of the decade.
Trump says US should do away with quarterly earnings reports
The Securities and Exchange Commission has required publicly traded companies to report on a quarterly basis since 1970.
Tech stocks are doing so well investors are starting to worry
Investors are betting on optimism regarding artificial intelligence and Federal Reserve interest-rate cuts to keep technology stocks moving higher.
World Health Organization adds Mounjaro to its list of essential medicines
The recommendation applies to a range of GLP-1 drugs that also includes Novo Nordisk’s Ozempic and Lilly’s older diabetes treatment, Trulicity.
US manufacturing activity contracts for 6th straight month
At the same time, there were a few hopeful signs about the outlook. Orders expanded for the first time since the start of the year.